Agritek Holdings Inc. (AGTK)

[steadykickin]

“Buckle up”? For what?

[jjr04001]

Again, what will you say when it goes above .04, .06, .1?

[steadykickin]

Out the gate with 514 shares traded....is that you?!

[steadykickin]

WARNING! Stay away from this toxic debt stock. WARNING!!

[steadykickin]

It hasn’t done shit so how can I be wrong. Anemic volume so having a large position is risky for an experienced trader. Every rise gets sold. This can’t hold any gains. Hang tight with your “boy” MF!

[steadykickin]

If you call that a “winner “ then you surely have very low expectations. LMAO.

[steadykickin]

OH yeah! Looks like you have yourself a real winner!

LMAO

[jjr04001]

Buckle up!! $AGTK

[jjr04001]

Friedman always comes through. $AGTK

[varjim]

Over 2 million now!

[jjr04001]

You were saying?

[varjim]

AGTK=65% up+ almost 2 million volume

[GeneGenie]

I'm still hoping for 2019 Financials and maybe even 2020, it is Christmas!

[steadykickin]

Booming volume 36,021....LMAO! Well to quote a saying from "The Grinch Who Stole Christmas"...."STINK..STANK...STUNK"!!

[Randyfloyd420]

Yes sir

[steadykickin]

Absolute dumpster material here!

[jjr04001]

It's coming. $AGTK

[Randyfloyd420]

Garbage!!!!!!!

[steadykickin]

No.

[jjr04001]

You own shares.

[steadykickin]

Looks like some insider share dumping going on. BEWARE!

[steadykickin]

Been hearing this for months and months...when is it going to run? Sounds like a broken record lol. Keeps going down down down.

[steadykickin]

You're proving my point for me .....this is a POS.

[steadykickin]

Every time you're "investing" (short or long term). Keep "learning", hopefully you'll get the hang of this. Good luck it sounds like you need it.

[steadykickin]

Traded this POS many times son. It's DONE. Sorry for your desperation to hope this will run again. How far are you in the RED BTW? Buy too high post split (again)?

[jjr04001]

You need to learn how to trade penny stocks. Only a fool compares these through the lens of "investment."

[steadykickin]

WARNING: DO NOT BUY THIS POS! Friedman is looking to take your money....not build anything of true value. Going sub-penny if Friedman doesn't prop up his own BS.

[steadykickin]

What would $100 be worth today if you had invested it in Friedman's BS 10 years ago.....answer is pennies (if you're lucky). Talk about following a bullshitter.......Friedman is the definition of BS. Well you know what they say...."Birds of a feather flock together". Talk about endorsing a BS POS. LMAO. NO volume= NO interest in this BS machine. 155,739 in volume on this POS lol.

[jjr04001]

You should join FOX, Trump and the Republican party if you haven't already, because all you're doing is spinning the facts.

Multibagger in progress $AGTK

[steadykickin]

It's your story. Tell it any way you like. ;)

[jjr04001]

I am. The stock found bottom then made 100 bags. Then reverse split. Then it found bottom again. Then 100 bags. Then reverse split. It found bottom again. I'm not denying that the stock is toast after a run, and that smart traders wait until after an RS for bottom. However, YOU'RE denying that it makes 100 bags after it finds bottom post rs.

[steadykickin]

Aaaaah but you're NOT including all the reverse splits !! Tisk Tisk Tisk!
That chart slopes DOWN.

[jjr04001]

2012-2013 run .25 to 250. 100 bags.
2016 .15 to 15. 100 bags.

[steadykickin]

"100 bags"....NEVER! Look at the chart for Friedman's scams for that last 10 years....BIG TIME downward slope.

[varjim]

Agritek Holdings Inc. Announces Executed Asset Purchase Agreement For Acquisition Of Full Spectrum Biosciences By Canada Based Primo Nutraceuticals Inc. Trading On CSE and OTC Exchanges
9:04 am ET November 12, 2020 (Accesswire) Print
LOS ANGELES, CA / ACCESSWIRE / November 12, 2020 / Agritek Holdings, Inc. (OTC PINK:AGTK) (www.AgritekHoldings.com), a fully integrated, active real estate investor and its wholly owned subsidiary Full Spectrum Biosciences Inc. an IP, formulation and white label provider for popular hemp brands RehabRx and Hemp Pops among others, today announced that Full Spectrum Biosciences Inc. and Primo Nutraceuticals Inc. (www.primonutraceuticals.com) a publically traded company on the CSE and OTC Exchange have executed a binding agreement and Letter of Intent for Primo Nutraceuticals to acquire all of of the intellectual property, brands and contracts of Full Spectrum Biosciences.

The transaction is expected to be completed before the end of fiscal year December 2020, with all of the listed assets of Full Spectrum within the definitive agreement to be acquired into a new acquisition corporation and wholly owned subsidiary of Primo Nutraceuticals.

The purchase price of the Full Spectrum Biosciences Assets will be based upon third party valuations ordered by Primo. Full Spectrum bioscience and shareholders will receive common shares of the Company (the "Common Shares") at a deemed price of $0.10 per Common Share. The closing of the Primo Nutraceuticals and Full Spectrum Biosciences Transaction are subject to the execution of the definitive agreement expected later next week and the customary closing conditions contained in transactions of this nature.

"We are quite enthusiastic to add the IP and multiple proven brands with additional revenue streams of Full Spectrum Biosciences to our portfolio before year end", said Richard Cindric, CEO. "We look forward to working together and building on our combined experience and efforts to expand our global footprint within the life sciences and cannabis nutraceutical and edibles sector", added Cindric.

"I am pleased to deliver on our promise to the Agritek shareholders that our wholly owned subsidiary Full Spectrum Biosciences has entered into this asset purchase agreement with Primo Nutraceuticals. By having access to both the Canadian and US public markets through Primo, we can work to build our company in both jurisdictions and bring greater value through our combined management teams and contacts. I have always believed that a nutraceutical and big pharma model would bring the most benefit to our company and shareholders, and Primo offers us the best opportunity, corporate structure and access to public markets to do just that. Our recently announced test pilot program with Biomedican using proprietary yeast for synthetic cannabinoid profiles propels our company to an entirely different level within the pharmaceutical space as a biotech with Primo. As we complete this transaction, we can then move to rebuild Agritek Holdings through completing our public filings, and bringing on an advisory firm for a meaningful go forward plan as a merger and acquisition company within the cannabis sector. I believe the new administration coming in 2021 will offer new opportunities within the cannabis space that have not allowed us to entirely pursue due to federal regulation. The recent move toward state and perhaps federal legalization will in my opinion allow us to be successful through an approved business model within the cannabis sector as we have been known in the past", stated B. Michael Friedman, CEO Agritek Holdings Inc.

[BravoMav]

Pretty sure my broker won’t allow purchases anymore. I keep a wandering eye on it, hasn’t done much really.

[jjr04001]

Buy at current levels. You can make 20 bags. Friedman's tickers usually run 100 bags from absolute bottom.

[BravoMav]

It opened up a bit below that after their 200/1 reverse split. Pathetic move by management

[jjr04001]

Never. 0.6 maybe

[BravoMav]

Brilliant, tell me when it hits my $3 break even point.

[varjim]

AGTK=quietly put out big news-shhhhh time to buy more

[jjr04001]

multi-bagger run happening

[whytestocks]

Just In: $AGTK Agritek Holdings, Inc. Announces Agreement Between Subsidiary Full Spectrum Biosciences Inc. and California Based Biomedican, to Produce First Yeast Based Cannabinoid Compounds

Synthetic CBG Nutraceutical Products in New Test Pilot Program LOS ANGELES, CA, Nov. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Agritek Holdings, Inc. ( AGTK ) ( www.AgritekHoldings.com ), a fully integrated, active real estate investor and its wh...

Find out more AGTK - Agritek Holdings, Inc. Announces Agreement Between Subsidiary Full Spectrum Biosciences Inc. and California Based Biomedican, to Produce First Yeast Based Cannabinoid Compounds

[JAH son]

AGTK link to today's breaking news:
https://finance.yahoo.com/news/agritek-holdings-inc-announces-agreement-151300190.html

[81vette]

Rare cannabinoids exist in minimal quantities in the cannabis plant, making their extraction and purification inefficient, costly, and environmentally taxing. Our revolutionary biosynthetic method reduces the production cost by 70-90% and shortens the time from several months to just a few days.
In contrast to the chemical synthesis of rare cannabinoids that creates non-naturally occurring forms, which can have unwanted side effects, our cannabinoids have the exact structures as naturally grown compounds.
Our proprietary oily yeast Yarrowia Lipolytica (YL) yields up to 80% of its weight in oils, making it an efficient micro-organism for producing large amounts of target compounds. The fermentation process is cheap and efficient, requiring only sugar, water, and YL yeast, reducing the production costs up to 70-90%.

[81vette]

The nutraceutical market demands carotenoids for many purposes. Just last year, the market for one carotenoid – astaxanthin became a billion-dollar industry. Not only are carotenoids efficient antioxidants in high demand in the dermatology and cosmetology sectors, but they have also been implicated in increasing overall blood flow and alleviating diabetes by reducing blood sugar.

[81vette]

Biomedican generates cannabinoids and terpenes directly from proprietary yeast without costly plant cultivation or inefficient extraction and purification procedures in a scalable fashion. Production facilities for biosynthesis cost a fraction of traditional cannabis facilities enabling much more cost-efficient manufacturing.



Biomedican research and production strategies are continuously improving. Our intellectual property portfolio keeps growing as we aim to streamline the production pipeline of pure and consistent compounds that are in high demand across many regions in the U.S. and Canada.



Investors benefit from the ability to participate in an industry currently gaining enormous momentum. Our proprietary technology can revolutionize the cannabinoid supply chain and directly feed into several markets where cannabinoids and terpenes are in high demand. As the production of cannabinoids and terpenes through biosynthesis is significantly quicker than traditional methods, investors can expect a faster return on investments.

[81vette]

insane good news(pot world changing),not on otc yet

[81vette]

pot stocks running last 2 days,low float AGTK

[81vette]

fresh news,yeast based pot deal